SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-08-005599
Filing Date
2008-08-14
Accepted
2008-08-14 15:25:10
Documents
4
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 RXI PHARMACEUTICALS CORPORATION b71164rce10vq.htm 10-Q 161767
2 EX-31.1 SECTION 302 CERTIFICATION OF THE CEO b71164rcexv31w1.htm EX-31.1 7614
3 EX-31.2 SECTION 302 CERTIFICATION OF THE CFO b71164rcexv31w2.htm EX-31.2 7621
4 EX-32.1 SECTION 906 CERTIFICATION OF THE CEO & CFO b71164rcexv32w1.htm EX-32.1 3999
  Complete submission text file 0000950135-08-005599.txt   182332
Mailing Address 60 PRESCOTT STREET WORCESTER MA 01605
Business Address 60 PRESCOTT STREET WORCESTER MA 01605 508-767-3861
RXI PHARMACEUTICALS CORP (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33958 | Film No.: 081018469
SIC: 2834 Pharmaceutical Preparations